-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>
On April 28 , 2022 , the research group of Professor Li Jixi of our school published a research paper entitled "Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma" in the journal " Journal of Inflammation Research" , systematically analyzed and identified chemokines Role in the prognosis of glioblastoma .
Glioblastoma ( GBM ) is the most common malignant tumor in the adult central nervous system, with high morbidity and mortality, lacking effective early diagnosis and treatment methods, and is considered to be the most difficult and refractory in neurosurgery.
Figure 1.
Li Jixi's research group from the School of Life Sciences, Fudan University has long been engaged in the research on cell death and immune response
Postdoctoral fellow Gao Wenqing and doctoral student Li Yuanyuan are the co-first authors of the paper, and Professor Li Jixi and Director Su Zhipeng of the Department of Neurosurgery of the First Affiliated Hospital of Wenzhou Medical University are the corresponding authors of the paper
Original link: https://
